Literature DB >> 6740917

Immunogenicity of a soluble antigen against Pasteurella haemolytica-associated pneumonia in calves.

M Matsumoto, J A Schmitz, B Syuto, B J Watrous, D E Mattson.   

Abstract

Three experiments were performed to evaluate the immunogenic potency of a soluble fraction of Pasteurella haemolytica against pneumonic pasteurellosis in calves. A soluble antigen was extracted by a 2.5% saline solution from P. haemolytica. Weaned Holstein bull calves, seronegative for infectious bovine rhinotracheitis virus ( IBRV ) and the pasteurella antigen, were vaccinated either by repeated subcutaneous (SC) vaccination, or by exposure 3 times to the aerosol of P. haemolytica antigen. Challenge exposure to aerosol of P. haemolytica was preceded by infection with IBRV , or in experiments 2 and 3, the virus exposures were combined with a stress treatment. The lung lesions were examined at necropsy 3 to 8 days post infection. In the first experiment, all the vaccinated calves produced specific antibody response to the pasteurella antigen, and none of the calves including controls showed significant lesions in the lung. In the second experiment 2 aerogenically vaccinated calves had no lesions. One of the two SC-vaccinated calves had mild consolidated lesions. Two control calves, one of which died 3 days following the challenge, developed severe fibrinous pneumonia with consolidation of 50% or more of the lung surfaces. P. haemolytica was isolated only from the 2 control animals. In the third experiment, 2 of the 3 control calves developed moderate to severe consolidation, but P. haemolytica was isolated only from one of them. Two of the three aerosol-vaccinated calves also developed significant lesions and one of them yielded the bacteria from the lung. Three SC-vaccinated calves had slight lesions and the organism was not isolated from their lungs. The results did not consistently indicate an immunogenic potential of the soluble antigen against P. haemolytica-related pneumonia. The effect of stress on the pathogenesis of bovine viral pneumonia and correlation between pneumonic lesions and antibacterial resistance in situ are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6740917     DOI: 10.1007/BF02214703

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  10 in total

1.  A four-year clinical and serologic study of the use of inactivated parainfluenza-3 virus vaccines and Pasteurella sp. bacterins in beef calves.

Authors:  G T Woods; M E Mansfield; G F Cmarik; G Marquis
Journal:  Vet Med Small Anim Clin       Date:  1974-04

2.  Comparison of Collison and De Vilbiss 65 nebulizers in the generation of aerosols for respiratory disease studies.

Authors:  W D Yates; G C Kozub; A R Lejeune
Journal:  Can J Comp Med       Date:  1981-10

3.  Response of calves to lung challenge exposure with Pasteurella haemolytica after parenteral or pulmonary immunization.

Authors:  B N Wilkie; R J Markham; P E Shewen
Journal:  Am J Vet Res       Date:  1980-11       Impact factor: 1.156

4.  Naturally occurring infection of calves with a bovine adenovirus.

Authors:  D E Mattson
Journal:  Am J Vet Res       Date:  1973-05       Impact factor: 1.156

5.  Experimental bovine pneumonic pasteurellosis. II. Genesis and prevention.

Authors:  P H Stockdale; K W Jericho; W D Yates; C Darcel; E V Langford
Journal:  Can J Comp Med       Date:  1979-07

6.  Bovine pneumonic pasteurellosis: experimental induction in vaccinated and nonvaccinated calves.

Authors:  S C Friend; B N Wilkie; R G Thomson; D A Barnum
Journal:  Can J Comp Med       Date:  1977-01

7.  Immunogenicity of capsular antigens of Pasteurella multocida in turkeys.

Authors:  H Kodama; M Matsumoto; L M Snow
Journal:  Am J Vet Res       Date:  1981-10       Impact factor: 1.156

8.  Correlation of microbiological and histological findings in bovine fibrinous pneumonia.

Authors:  B Schiefer; G E Ward; R E Moffatt
Journal:  Vet Pathol       Date:  1978-05       Impact factor: 2.221

9.  Distribution of Pasteurella haemolytica and Pasteurella multocida in the bovine lung following vaccination and challenge exposure as an indicator of lung resistance.

Authors:  P R Newman; R E Corstvet; R J Panciera
Journal:  Am J Vet Res       Date:  1982-03       Impact factor: 1.156

10.  Purification of a protective antigen from a saline extract of Pasteurella multocida.

Authors:  B Syuto; M Matsumoto
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

  10 in total
  3 in total

1.  Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis.

Authors:  D A Mosier; K R Simons; A W Confer; R J Panciera; K D Clinkenbeard
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Preliminary studies with a live streptomycin-dependent Pasteurella multocida and Pasteurella haemolytica vaccine for the prevention of bovine pneumonic pasteurellosis.

Authors:  D M Catt; M M Chengappa; W L Kadel; C E Herren
Journal:  Can J Comp Med       Date:  1985-10

3.  Detection of immunoglobulin G to Pasteurella haemolytica capsular polysaccharide by enzyme-linked immunosorbent assay.

Authors:  E L Townsend; S K Maheswaran; J R Leininger; T R Ames
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.